Involvement of PyVs in bladder cancer has long been suspected and the A3 mutational signature found in bladder tumors has been proposed to be the result of a hit-and-run mechanism where PyV triggers a strong A3B expression [44]. Here, APOBEC3B is linked to urinary bladder cancer.